NCT05850702

Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine

Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine: a Randomized, Double-blind, Controlled Trial

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 92 (estimated)
• Sponsor: RenJi Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to test the effect of nebulized lidocaine on the hemodynamic response in the participant undergoing double-lumen endotracheal intubation. The main question it aims to answer is to evaluate the changes in mean arterial pressure after intubation. Participants will inhale 5ml of 2% lidocaine by nebulization15min before intubation. Researchers will compare saline group to see if saline effects

Conditions

• Lung Neoplasms

Interventions

Type	Name	Description
DRUG	Lidocaine	inhale 5ml of 2% lidocaine by nebulization
DRUG	Saline	inhale 5ml of saline by nebulization

Timeline

• Start date: 2023-06-15
• Primary completion: 2025-03-09
• Completion: 2025-09-09
• First posted: 2023-05-09
• Last updated: 2023-05-09